
Opinion|Videos|October 17, 2024
Overview of Idiopathic Pulmonary Fibrosis (IPF)
Author(s)Toby Maher, MD, PhD
Key Takeaways
- IPF is a chronic, progressive lung disease marked by lung tissue thickening and scarring, leading to reduced lung function.
- It is a specific type of interstitial lung disease, which includes various disorders affecting lung interstitium.
Toby Maher, MD, PhD, discusses how idiopathic pulmonary fibrosis (IPF) is a specific form of interstitial lung disease characterized by progressive lung scarring, which leads to significant respiratory impairment and distinct clinical challenges compared with other interstitial lung diseases.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What is IPF, and how does IPF compare with interstitial lung disease?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads
2
New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform
3
Overcoming Mistrust in Clinical Trial Enrollment Through Community Resources: Susan Vadaparampil, PhD, MPH
4
Medicare’s 3-Day Rule Reinstatement Lengthened Hospital Stays Without Cost, Outcome Benefits
5













